AAAAAA
Results:
1-14
|
Results: 14
Authors:
ZIEDONIS D
HARRIS P
BRANDT P
TRUDEAU K
GEORGE T
RAO S
TANAGHO A
KOSTEN T
Citation: D. Ziedonis et al., MOTIVATIONAL ENHANCEMENT THERAPY AND NICOTINE REPLACEMENT IMPROVE SMOKING CESSATION OUTCOMES FOR SMOKERS WITH SCHIZOPHRENIA OR DEPRESSION, Addiction, 92(5), 1997, pp. 633-633
Authors:
ZIEDONIS D
BRADY K
Citation: D. Ziedonis et K. Brady, DUAL DIAGNOSIS IN PRIMARY-CARE - DETECTING AND TREATING BOTH THE ADDICTION AND MENTAL-ILLNESS, The Medical clinics of North America, 81(4), 1997, pp. 1017
Authors:
SCHOTTENFELD RS
PAKES JR
OLIVETO A
ZIEDONIS D
KOSTEN TR
Citation: Rs. Schottenfeld et al., BUPRENORPHINE VS METHADONE-MAINTENANCE TREATMENT FOR CONCURRENT OPIOID DEPENDENCE AND COCAINE ABUSE, Archives of general psychiatry, 54(8), 1997, pp. 713-720
Authors:
HUGHES JR
FIESTER S
GOLDSTEIN M
RESNICK M
ROCK N
ZIEDONIS D
MCINTYRE JS
CHARLES SC
ZARIN DA
PINCUS HA
ALTSHULER KZ
AYRES WH
BITTKER T
BLINDER B
CLAYTON PJ
COOK I
DICKSTEIN L
EGGER H
FLAMM G
JAFFE S
MILLER S
MOENCH LA
PEELE R
PHARSSIS B
YAGER J
NORQUIST G
HARDING RK
KENT J
OLDHAM J
GOIN M
LYMBERIS M
GOLDSTEIN M
FLYNN L
HERZOG A
NININGER J
URBAITIS J
MARGOLIS P
KAYSER A
LURIE L
WALKER RD
SEIGLE L
Citation: Jr. Hughes et al., PRACTICE GUIDELINE FOR THE TREATMENT OF PATIENTS WITH NICOTINE DEPENDENCE, The American journal of psychiatry, 153(10), 1996, pp. 1-31
Authors:
OLIVETO A
KOSTEN TR
SCHOTTENFELD R
FALCIONI J
ZIEDONIS D
Citation: A. Oliveto et al., DESIPRAMINE, AMANTADINE, OR FLUOXETINE IN BUPRENORPHINE-MAINTAINED COCAINE USERS, Journal of substance abuse treatment, 12(6), 1995, pp. 423-428
Authors:
FARREN CK
CLARE AW
ZIEDONIS D
HAMMEEDI FA
DINAN TG
Citation: Ck. Farren et al., EVIDENCE FOR REDUCED DOPAMINE D2 RECEPTOR SENSITIVITY IN POSTWITHDRAWAL ALCOHOLICS, Alcoholism, clinical and experimental research, 19(6), 1995, pp. 1520-1524
Authors:
FARREN CK
ZIEDONIS D
CLARE AW
HAMMEEDI FA
DINAN TG
Citation: Ck. Farren et al., D-FENFLURAMINE-INDUCED PROLACTIN RESPONSES IN POSTWITHDRAWAL ALCOHOLICS AND CONTROLS, Alcoholism, clinical and experimental research, 19(6), 1995, pp. 1578-1582
Authors:
RAO S
ZIEDONIS D
KOSTEN T
Citation: S. Rao et al., THE PHARMACOTHERAPY OF COCAINE DEPENDENCE, Psychiatric annals, 25(6), 1995, pp. 363-368
Authors:
OLIVETO AH
KOSTEN TR
SCHOTTENFELD R
ZIEDONIS D
FALCIONI J
Citation: Ah. Oliveto et al., COCAINE USE IN BUPRENORPHINE-MAINTAINED VS METHADONE-MAINTAINED PATIENTS, The American journal on addictions, 3(1), 1994, pp. 43-48
Authors:
LEAL J
ZIEDONIS D
KOSTEN T
Citation: J. Leal et al., ANTISOCIAL PERSONALITY-DISORDER AS A PROGNOSTIC FACTOR FOR PHARMACOTHERAPY OF COCAINE DEPENDENCE, Drug and alcohol dependence, 35(1), 1994, pp. 31-35
Authors:
KOSTEN TR
SCHOTTENFELD R
ZIEDONIS D
FALCIONI J
Citation: Tr. Kosten et al., COMPARING BUPRENORPHINE AND METHADONE-MAINTENANCE - REPLY, The Journal of nervous and mental disease, 182(4), 1994, pp. 246-246
Authors:
KOSTEN TR
SCHOTTENFELD R
ZIEDONIS D
FALCIONI J
Citation: Tr. Kosten et al., BUPRENORPHINE VERSUS METHADONE-MAINTENANCE FOR OPIOID DEPENDENCE, The Journal of nervous and mental disease, 181(6), 1993, pp. 358-364
Authors:
SCHOTTENFELD RS
PAKES J
ZIEDONIS D
KOSTEN TR
Citation: Rs. Schottenfeld et al., BUPRENORPHINE - DOSE-RELATED EFFECTS ON COCAINE AND OPIOID USE IN COCAINE-ABUSING OPIOID-DEPENDENT HUMANS, Biological psychiatry, 34(1-2), 1993, pp. 66-74
Authors:
OLIVETO A
KOSTEN T
SCHOTTENFELD R
ZIEDONIS D
Citation: A. Oliveto et al., COCAINE ABUSE AMONG METHADONE-MAINTAINED PATIENTS, The American journal of psychiatry, 150(11), 1993, pp. 1755-1755
Risultati:
1-14
|